NCL-17093-81861
3 vaccinations
2 coded responses
24 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 207 / MD
- Registered
- 2021-01-25
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Registered dependents
PC9-12078-97681
Child or adolescent in my care · Male · 2021-11-06
Timeline
-
2021-01-25
Registered in v-safe
-
2021-01-25
Dose 1 — Pfizer-BioNTech
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-01-28
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-08
- 2021-02-15
-
2021-02-19
Dose 2 — Pfizer-BioNTech
- 2021-02-19
-
2021-02-20
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · HeadacheAdult check-in
- 2021-02-22
- 2021-02-23
- 2021-02-28
- 2021-03-05
- 2021-04-04
-
2021-05-21
Survey response — 3 months, dose 2MedDRA: Menstrual disorder — Feeling: GoodFree text: Have not had a normal menstrual cycle since vaccinationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-10-03
Dose 3 — Pfizer-BioNTech
- 2021-11-06
- 2021-11-07
- 2021-11-15
- 2022-01-02
- 2022-04-03
-
2022-10-03
Survey response — 12 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Covid; unborn baby was diagnosed with IUGRMedDRA releases: 2024-11 · check-in free text available
-
2022-10-03
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-25 | Pfizer-BioNTech | |
| 2 | 2021-02-19 | Pfizer-BioNTech | |
| 3 | 2021-10-03 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 8 — 3 months, dose 2
Symptoms: Have not had a normal menstrual cycle since vaccination
Release 12 — 12 months, dose 3
Symptoms: Covid; unborn baby was diagnosed with IUGR
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Menstrual disorder | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release